Ads
related to: molecular breast imaging results centercancer.osu.edu has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Molecular breast imaging (MBI), also known as scintimammography, is a type of breast imaging test that is used to detect cancer cells in breast tissue of individuals who have had abnormal mammograms, especially for those who have dense breast tissue, post-operative scar tissue or breast implants. [1]
Positron emission mammography (PEM) is a nuclear medicine imaging modality used to detect or characterise breast cancer. [1] Mammography typically refers to x-ray imaging of the breast, while PEM uses an injected positron emitting isotope and a dedicated scanner to locate breast tumors.
Molecular breast imaging is a nuclear medicine technique that is currently under study. It shows promising results for imaging people with dense breast tissue and may have accuracies comparable to MRI. [44] It may be better than mammography in some people with dense breast tissue, detecting two to three times more cancers in this population. [44]
Stratification for breast cancer risk on a mammogram is based on a reporting system known as Breast Imaging-Reporting and Data System , developed by the American College of Radiology in 1993. It has five general categories of findings: mass, asymmetry, architectural distortion, calcifications, and associated features.
Breast ultrasound is another technology employed in diagnosis and screening that can help differentiate between fluid filled and solid lesions, an important factor to determine if a lesion may be cancerous. [2] Breast MRI is a technology typically reserved for high-risk patients and patients recently diagnosed with breast cancer. [3]
Rachel F. Brem is an American diagnostic radiologist, professor of radiology at the George Washington University School of Medicine & Health Sciences, and director of the Breast Imaging and Interventional Center at George Washington University’s Cancer Center. She previously served as director of Breast Imaging at Johns Hopkins.
Ad
related to: molecular breast imaging results center